Full Text
The Full Text of this article is available as a PDF (27.1 KB).
. 2006 Nov 15;22(4):183–185. doi: 10.1155/2006/508354
Biomarkers in Multiple Sclerosis
Roland Martin
1, Bibiana Bielekova
2, Reinhard Hohlfeld
3, Ursula Utz
4,*
Roland Martin
1Catalan Institute for Research and Advanced Studies and Unidad de Neuroimmunologia Clinica, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Roland Martin
Bibiana Bielekova
2Department of Neurology, Waddel Center for MS, University of Cincinnati & The Neuroscience Institute, Cincinnati, OH, USA
Find articles by Bibiana Bielekova
Reinhard Hohlfeld
3Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, Martinsried, Munich, Germany
Find articles by Reinhard Hohlfeld
Ursula Utz
4Division of Extramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
Find articles by Ursula Utz
1Catalan Institute for Research and Advanced Studies and Unidad de Neuroimmunologia Clinica, Hospital Universitari Vall d’Hebron, Barcelona, Spain
2Department of Neurology, Waddel Center for MS, University of Cincinnati & The Neuroscience Institute, Cincinnati, OH, USA
3Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, Martinsried, Munich, Germany
4Division of Extramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
✉
*Ursula Utz: utzu@ninds.nih.gov
Received 2006 Nov 10; Accepted 2006 Nov 10; Issue date 2006.
Copyright © 2006 Hindawi Publishing Corporation.
PMCID: PMC3851393 PMID: 17124339